Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple Sclerosis Drug Fingolimod Exhibits Antibacterial Activity through Bacterial Membrane Permeabilization.
Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neuropathy: mechanisms, exposure challenges, and translational priorities.
Investigational approaches to multiple sclerosis therapy.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: Yes.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: Commentary.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO.
Zebrafish (Danio rerio) as a Model for Neurodegenerative Disease Research: Mechanisms, Biomarkers, and Translational Promise.
Immune-Related Polyradiculoneuropathy Associated With Immune Checkpoint Inhibitors: A Comprehensive Case Series.
Clinicoradiologic profile of neuromyelitis optica spectrum disorder in a Kashmiri cohort: a prospective observational cohort study.
Rigorous genetic diagnosis review in natural history studies.
Evaluating nurse-led self-regulation in multiple sclerosis management with an interactive web-based program: a randomized controlled trial.
A telomere-lipid-immunity axis linking viral integration to autoimmune disease risk.
Molecular dynamics simulations along with the synthesis of innovative engineered nanobodies targeting Interleukin-2.
Use of semaglutide and tirzepatide among people with multiple sclerosis.
Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy - a post-hoc analysis.

Pages